Literature DB >> 25824845

Polio vaccination: past, present and future.

Ananda S Bandyopadhyay, Julie Garon1, Katherine Seib1, Walter A Orenstein1.   

Abstract

Live attenuated oral polio vaccine (OPV) and inactivated polio vaccine (IPV) are the tools being used to achieve eradication of wild polio virus. Because OPV can rarely cause paralysis and generate revertant polio strains, IPV will have to replace OPV after eradication of wild polio virus is certified to sustain eradication of all polioviruses. However, uncertainties remain related to IPV's ability to induce intestinal immunity in populations where fecal-oral transmission is predominant. Although substantial effectiveness and safety data exist on the use and delivery of OPV and IPV, several new research initiatives are currently underway to fill specific knowledge gaps to inform future vaccination policies that would assure polio is eradicated and eradication is maintained.

Entities:  

Keywords:  disease eradication; inactivated polio vaccine; polio end game; vaccine technology

Mesh:

Substances:

Year:  2015        PMID: 25824845     DOI: 10.2217/fmb.15.19

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  77 in total

Review 1.  Polio elimination in Nigeria: A review.

Authors:  Usman Nakakana Nasir; Ananda Sankar Bandyopadhyay; Francesca Montagnani; Jacqueline Elaine Akite; Etaluka Blanche Mungu; Ifeanyi Valentine Uche; Ahmed Mohammed Ismaila
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Prevalence of poliovirus vaccine strains in randomized stool samples from 2010 to 2018: encompassing transition from the trivalent to bivalent oral poliovirus vaccine.

Authors:  Jira Chansaenroj; Watchaporn Chuchaona; Thanundorn Thanusuwannasak; Ausanee Duang-In; Jiratchaya Puenpa; Viboonsak Vutithanachot; Sompong Vongpunsawad; Yong Poovorawan
Journal:  Virusdisease       Date:  2019-03-21

3.  Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization.

Authors:  Jennifer L Konopka-Anstadt; Ray Campagnoli; Annelet Vincent; Jing Shaw; Ling Wei; Nhien T Wynn; Shane E Smithee; Erika Bujaki; Ming Te Yeh; Majid Laassri; Tatiana Zagorodnyaya; Amy J Weiner; Konstantin Chumakov; Raul Andino; Andrew Macadam; Olen Kew; Cara C Burns
Journal:  NPJ Vaccines       Date:  2020-03-20       Impact factor: 7.344

4.  2'-C-methylated nucleotides terminate virus RNA synthesis by preventing active site closure of the viral RNA-dependent RNA polymerase.

Authors:  Alyson K Boehr; Jamie J Arnold; Hyung S Oh; Craig E Cameron; David D Boehr
Journal:  J Biol Chem       Date:  2019-10-01       Impact factor: 5.157

5.  Immunogenicity of sequential inactivated and oral poliovirus vaccines (OPV) versus inactivated poliovirus vaccine (IPV) alone in healthy infants: A systematic review and meta-analysis.

Authors:  Guihua Tang; Wen Yin; Youde Cao; Liming Tan; Shuyu Wu; Yudong Cao; Xianyong Fu; Jing Yan; Xingjun Jiang
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

Review 6.  Pharmaceutical drug development: high drug prices and the hidden role of public funding.

Authors:  Stephanie Annett
Journal:  Biol Futur       Date:  2020-06-22

7.  Polio switch strategy: An obituary in the making?

Authors:  M S Mustafa; V Rastogi; P M P Singh
Journal:  Med J Armed Forces India       Date:  2020-09-28

8.  A Live-Attenuated Zika Virus Vaccine with High Production Capacity Confers Effective Protection in Neonatal Mice.

Authors:  Xianmiao Ye; Xinglong Liu; Ling Chen; Feng Li; Liqiang Feng; Tao Shu; Weiqi Deng; Min Liao; Yali Zheng; Xuehua Zheng; Xiaoyan Zhang; Ting Li; Wenxia Fan; Linbing Qu
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

9.  Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines.

Authors:  Yoshikazu Honda-Okubo; Jeremy Baldwin; Nikolai Petrovsky
Journal:  Pathogens       Date:  2021-04-21

Review 10.  COVID-19 Vaccines (Revisited) and Oral-Mucosal Vector System as a Potential Vaccine Platform.

Authors:  Muhammad Umer Ashraf; Yeji Kim; Sunil Kumar; Dongyeob Seo; Maryam Ashraf; Yong-Soo Bae
Journal:  Vaccines (Basel)       Date:  2021-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.